George Oprita

Mr. George Oprita

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Sebastian PantkeSebastian Pantke
Sebastian Pantke
JSJohanna Steinberg
Johanna Steinberg
LWLucas Weber
Lucas Weber
TFTabea Caroline Fricke
Tabea Caroline Fricke
ISInês Carvalheira Arnaut Pombeiro Stein
Inês Carvalheira Arnaut Pombeiro Stein
ALAndreas Leffler
Andreas Leffler
Background: A large number of patients suffer from neuropathic pain, and systemic therapy often remains ineffective while inducing severe side effects. Topical therapy with the TRPV1-agonist capsaicin is an established alternative, and the identification of co-therapeutics that modulate TRPV1 may be a promising approach to reduce the dose of capsaicin while maintaining efficacy. Here, we aimed to determine if the antidepressant amitriptyline displays properties rendering it a potential co-therapeutic agent. Methods: We performed patch clamp and calcium imaging experiments on HEK293T cells expressing human (h) TRPV1 as well as on dorsal root ganglion (DRG) neurons from adult mice. Results: Amitriptyline induced an increase in intracellular calcium in both HEK293T and mouse DRG neurons expressing TRPV1. Patch clamp experiments revealed a concentration-dependent activation of hTRPV1 by amitriptyline that was also evident in cell-free inside-out patches. When hTRPV1 was fully activated by capsaicin, amitriptyline induced concentration-dependent and partly reversible current inhibition. In contrast, amitriptyline potentiated small responses to capsaicin, heat and protons. We also found that amitriptyline desensitized hTRPV1 to capsaicin. This effect was reduced by the intracellular application of the strong calcium chelator BAPTA. Furthermore, the non-desensitizing mutant hTRPV1-Y672K displayed a reduced amitriptyline-induced desensitization. Conclusions: Our data showed that amitriptyline can activate, sensitize, desensitize and even inhibit TRPV1. Together with its property as a strong local anesthetic, our data suggest that amitriptyline may be a promising adjunct to topical capsaicin.

1 October 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GOGeorge Oprita
George Oprita
DDDan Domocos
Dan Domocos
TSTudor Selescu
Tudor Selescu
APAdelina Paduraru
Adelina Paduraru
Sorin TunaruSorin Tunaru
Sorin Tunaru
RBRamona Madalina Babes
Ramona Madalina Babes

20 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
TFTabea C. Fricke
Tabea C. Fricke
RPRuth A. Pumroy
Ruth A. Pumroy
JRJulia A. Rocereta
Julia A. Rocereta
JJJosé J. De Jesús-Pérez
José J. De Jesús-Pérez
GOGeorge Oprita
George Oprita
VMVera Y. Moiseenkova-Bell
Vera Y. Moiseenkova-Bell
Transient receptor potential vanilloid 2 (TRPV2) is a broadly expressed ion channel implicated in diverse physiological and pathological processes. Despite strong conservation, human TRPV2 (hTRPV2) displays markedly reduced sensitivity to stimuli such as 2-aminoethoxydiphenyl borate (2-APB) and heat compared to rodent orthologs. Here we combine electrophysiology and cryo electron microscopy to define the basis of this species-dependent divergence. The structure of hTRPV2 is remarkably different at the voltage sensor-like domain (VSLD) compared to rodent channels and functional analyses show a graded activity profile between human, mouse and rat TRPV2 to a broad range of chemical and physical stimuli. Three residues located between S6 and the TRP domain tune this functional difference, as reciprocal substitutions exchange current phenotypes. hTRPV2 structures of this mutant reveal coupling between the mutation site and the VSLD as well as an additional binding site for 2-APB. Together, these findings define structural determinants of species-specific TRPV2 function.